I live in India and my son (9yr old) has Type 1 and is currently on injections twice a day. Am looking to buy the pump for him and I had a trial run on 722 model and I found it quite convenient and comfortable for my son.
Now am told there is a 'better' model 754 from Medtronics and am recommended to buy it rather than 722 model.
I have tried to look for comparison for these two models but I couldnt . Can anyone please share your experience in using these two models from a comparison perspective and any technical convenience in buying the 754 model.
Please provide your opinions
I live in a backwards country (USA) where we don't have the 754, we have the 723. I had the 722 for several years and switched to the 523 as I realized I don't need that much insulin and like the slightly smaller pump.
The -23 series pumps w/ CGM hint at what the Veo does with the "Predicted Low/ Predicted High" alerts. I have found these very effective. I come home from work, check my BG, it's 85, I'll have a glass of skim milk and get changed. As I start out, the CGM will alert me to a "Predicted High" as it notes the increasing BG. The 523 doesn't do anything at this point but I'm running and don't worry about it.
About 2 miles into a 3 mile run, it will often follow with a "Predicted Low" as my BG "rolls over" and starts going down. I've read that the -54 series pumps (Veo) will turn off the basal at this point. I would prefer that it not actually do this, as I usually run fastest as I get close to home since I figure I might as well get it over with and see a slight spike. For parents, depending on how you run your show, I think many of them will find this reassuring that if their BG runs low, it will cut off the basal to help with the turnaround. I'd need more info to say if your son really would need it but the 754 is Medtronics latest technology and I would have bought it if I could.
I think it also uses their latest sensor, the Enlite, which I've read is more accurate than the Paradigm model available in the US. I don't know if the "free book offer" on the right side of the page is still available on the right side of the page but that might be interesting for you if it's still there. Here's a link to a thread discussing a presentation by Dr. Francine Kaufman, who wrote the book and works for Medtronic: LINKthat has some more discussion you may find interesting. In the Video you can watch her video from last week. Somewhere, there's a presentation, a power point sort of thing that goes long with her speaking but I'm not sure where they put that?
As AC mentioned, the primary difference is that the 754 model supports the 'low glucose suspend' feature, which means if you also use the CGMS, then the pump will stop delivering insulin when the CGMS detects low BG (and you have set the option on).
Here is a link to 724 details.
The 754 is also called the Veo, and is not yet available in US. In countries where it is available, I'd be surprised if they would still also offer the 722/723 (Revel). There were minor differences between the 722 and 723.
For a child, the 5xx series may be more appropriate, as the only difference is a smaller size, and smaller cartridge for the insulin. So the 554 and 754 would be identical except for the maximum amount of insulin it can hold (1.8 vs 3.0).
The 554/754 is the latest model of the 'Minimed Paradigm' series. If CGMS is used with it, it is an improved sensor (Elite), compared to that used with the 722/723.
If you are not planning to use CGMS, then the 722/723/754 are pretty much the same.
Sorry to highjack this thread but the 530G/VEO may be available by late spring this year as soon as it is approved by the FDA. See the Diabtribe site and do a search. I believe I saw this in the August-October issues. It mentions by June 2013.